(1)
Anwar, K.; Sanjaya, S.; Ayu, R.; Sani, F. Safety and Efficacy of Subretinal AAV-CRISPR/Cas9 Gene Editing for Rhodopsin-Mutant Retinitis Pigmentosa: A Phase I/IIa Dose-Escalation Triall. sjo 2026, 8, 478-485.